Paper41322142
Multifunctional DSF-loaded ICG-chelated nanozyme for four-in-one enhanced synergistic tumor therapy.
Hu K and 6 others. Mater Today Bio, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Multifunctional DSF-loaded ICG-chelated nanozyme for four-in-one enhanced synergistic tumor therapy. Papers, record 41322142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41322142
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Multifunctional DSF-loaded ICG-chelated nanozyme for four-in-one enhanced synergistic tumor therapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32622254 | ICG-loaded gold nano-bipyramids with NIR activatable dual PTT-PDT therapeutic potential in melanoma cells. | Colloids Surf B Biointerfaces | 2020 | https://conductscience.org/library/papers/32622254 | PubMed |
| 2 | 29967547 | Standardized assays for determining the catalytic activity and kinetics of peroxidase-like nanozymes. | Nat Protoc | 2018 | https://conductscience.org/library/papers/29967547 | PubMed |
| 3 | 38904428 | Engineering of a double targeting nanoplatform to elevate ROS generation and DSF anticancer activity. | J Mater Chem B | 2024 | https://conductscience.org/library/papers/38904428 | PubMed |
| 4 | 38678042 | Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/38678042 | PubMed |
| 5 | 35794980 | Singlet Oxygen, Photodynamic Therapy, and Mechanisms of Cancer Cell Death. | J Oncol | 2022 | https://conductscience.org/library/papers/35794980 | PubMed |
| 6 | 31119258 | Nanozyme: new horizons for responsive biomedical applications. | Chem Soc Rev | 2019 | https://conductscience.org/library/papers/31119258 | PubMed |
| 7 | 39821694 | LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance. | Cancer Metastasis Rev | 2025 | https://conductscience.org/library/papers/39821694 | PubMed |
| 8 | 37506794 | Hyaluronic acid-based prodrug nanomedicines for enhanced tumor targeting and therapy: A review. | Int J Biol Macromol | 2023 | https://conductscience.org/library/papers/37506794 | PubMed |
| 9 | 21495033 | The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. | J Surg Oncol | 2011 | https://conductscience.org/library/papers/21495033 | PubMed |
| 10 | 39150904 | Four Birds with One Stone: A Bandgap-Regulated Multifunctional Schottky Heterojunction for Robust Synergistic Antitumor Therapy upon Endo-/Exogenous Stimuli. | ACS Nano | 2024 | https://conductscience.org/library/papers/39150904 | PubMed |
| 11 | 36882139 | European cancer mortality predictions for the year 2023 with focus on lung cancer. | Ann Oncol | 2023 | https://conductscience.org/library/papers/36882139 | PubMed |
| 12 | 39613128 | One stone, three birds: Construction of Cu/ZIF-8@DSF@GOx/HA nanoplatform for synergistic starvation therapy enhanced chemo-/chemodynamic therapy. | Nanomedicine | 2025 | https://conductscience.org/library/papers/39613128 | PubMed |
| 13 | 40225567 | Macrophage membrane-functionalized nanotherapeutics for tumor targeted therapy. | Theranostics | 2025 | https://conductscience.org/library/papers/40225567 | PubMed |
| 14 | 38490191 | Single Atom Catalysts Remodel Tumor Microenvironment for Augmented Sonodynamic Immunotherapy. | Adv Mater | 2024 | https://conductscience.org/library/papers/38490191 | PubMed |
| 15 | 31508286 | Cytomembrane-Mediated Transport of Metal Ions with Biological Specificity. | Adv Sci (Weinh) | 2019 | https://conductscience.org/library/papers/31508286 | PubMed |
| 16 | 39850244 | Multifunctional drug delivery nanoparticles for combined chemotherapy/chemodynamic/photothermal therapy against colorectal cancer through synergistic cuproptosis/ferroptosis/apoptosis. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/39850244 | PubMed |
| 17 | 39797461 | Hypoxia-Responsive Covalent Organic Framework Nanoplatform for Breast-Cancer-Targeted Cocktail Immunotherapy via Triple Therapeutic Switch Mechanisms. | Small | 2025 | https://conductscience.org/library/papers/39797461 | PubMed |
| 18 | 39194645 | Iron Oxide Nanoparticles: Parameters for Optimized Photoconversion Efficiency in Synergistic Cancer Treatment. | J Funct Biomater | 2024 | https://conductscience.org/library/papers/39194645 | PubMed |
| 19 | 40142970 | Anti-Tumor Strategies of Photothermal Therapy Combined with Other Therapies Using Nanoplatforms. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40142970 | PubMed |
| 20 | 39963718 | Oxygen Nanobubbles Enhance ICG/Fe(III)-Mediated Dual-Modal Therapy To Induce Ferroptosis in Tumor Treatment. | ACS Appl Mater Interfaces | 2025 | https://conductscience.org/library/papers/39963718 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42569610 | Nanosystem-Mediated Phototherapy (PDT/PTT) - Chemodynamic Therapy for Synergistic Antitumor Therapy: Strategies and Advances. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42569610 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CAT | 847 | PubTator's text mining | https://conductscience.org/library/genes/847 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41322142
GET https://conductscience.org/api/papers/v1/41322142/references?page=2